WAM
BMRN icon

Wealthspire Advisors (Maryland)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,414
Closed -$1.16M – 494
2020
Q2 		$1.16M Sell
9,414
-654
-6% -$65K 0.08% 143
2020
Q1 		$851K Buy
10,068
+3,310
+49% +$285K 0.07% 158
2019
Q4 		$571K Sell
6,758
-2,040
-23% -$154K 0.04% 255
2019
Q3 		$593K Buy
8,798
+295
+3% +$22.7K 0.04% 230
2019
Q2 		$728K Sell
8,503
-9
-0.1% -$770 0.05% 186
2019
Q1 		$756K Sell
8,512
-858
-9% -$79.5K 0.06% 176
2018
Q4 		$798K Buy
9,370
+718
+8% +$68.3K 0.07% 143
2018
Q3 		$839K Buy
8,652
+1,505
+21% +$150K 0.07% 166
2018
Q2 		$673K Buy
7,147
+1,164
+19% +$102K 0.06% 185
2018
Q1 		$485K Buy
5,983
+2,257
+61% +$194K 0.05% 252
2017
Q4 		$332K Sell
3,726
-1,111
-23% -$96.6K 0.03% 345
2017
Q3 		$450K Buy
4,837
+108
+2% +$9.54K 0.05% 257
2017
Q2 		$429K Buy
4,729
+512
+12% +$46.6K 0.05% 258
2017
Q1 		$370K Buy
4,217
+4,177
+10,443% +$372K 0.05% 245
2016
Q4 		$3K Hold
40
– – ﹤0.01% 1462
2016
Q3 		$4K Hold
40
– – ﹤0.01% 1419
2016
Q2 		$3K Hold
40
– – ﹤0.01% 1422
2016
Q1 		$3K Buy
40
+15
+60% +$1.22K ﹤0.01% 1435
2015
Q4 		$3K Buy
+25
New +$2.61K ﹤0.01% 1445

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s BMRN Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2020, closing a stake of 9,414 shares — an estimated $1.16M sold.

Wealthspire Advisors (Maryland) first reported a position in BMRN in Q4 2015 and held it in 19 quarters. The position peaked at $1.16M in Q2 2020. 497 funds tracked by Wall St. Rank hold BMRN as of Q3 2020.

  • Wealthspire Advisors (Maryland) reported no remaining BioMarin Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 9,414 BioMarin Pharmaceuticals shares in Q3 2020, an estimated $1.16M.
  • Wealthspire Advisors (Maryland) first reported a position in BioMarin Pharmaceuticals in Q4 2015 and held it in 19 quarters.
  • Wealthspire Advisors (Maryland)'s BioMarin Pharmaceuticals position peaked at $1.16M in Q2 2020.
  • 497 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.